Current Insights into the Phytochemistry, Traditional, and Biological Importance of Matricaria pubescens (Desf.) Schultz.

Authors

Smail Amtaghri, Corinne Raïssa Ngnameko, Motlalepula G Matsabisa

Published in

Endocrine, metabolic & immune disorders drug targets. Sep 01, 2026. Epub Sep 01, 2026.

Abstract

The purpose of this review is to examine M. pubescens's pharmacological, phytochemical, and toxicological properties. Furthermore, the study intends to explore and disseminate all relevant facts and information regarding this species' chemical compounds and medicinal uses.
This investigation was conducted using a range of scholarly resources, including ScienceDirect, Scopus, PubMed, and Google Scholar. Plantlist.org was used to verify the correct plant names. The bibliographic material retrieved was used to interpret, analyze, and document the findings of this inquiry.
This plant is commonly used in conventional medicine due to its high content of phytochemicals. These chemical compounds, known as secondary metabolites, include phenols, flavonoids, terpenes, alkaloids, and tannins, and are associated with medicinal properties. These chemicals are ideal for modern medicinal use because of their antibacterial, antioxidant, antifungal, antiinflammatory, antidiabetic, and antihypertensive activities. As our scientific understanding of their biological properties deepens, plant secondary metabolites are increasingly being used as medicines and food additives for flavoring and cooking.
This study provides a thorough analysis of the pharmacological and medicinal properties of M. pubescens. Despite this, studies in the literature have shown that M. pubescens is a valuable medicinal resource with a range of pharmacological properties. It is a strong candidate for research and the development of new therapeutic treatments because it has demonstrated a variety of pharmacological traits that support its traditional use.
This review focuses on the distribution, chemistry, and principal applications of M. pubescens, identifying potential research and the exploration of medicinal uses through clinical trials.

PMID:
42708317
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.